BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10602670)

  • 1. Antibiotics and Clostridium difficile.
    Freeman J; Wilcox MH
    Microbes Infect; 1999 Apr; 1(5):377-84. PubMed ID: 10602670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
    Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
    Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile recurrent infection: possible implication of TA systems.
    Gil F; Pizarro-Guajardo M; Álvarez R; Garavaglia M; Paredes-Sabja D
    Future Microbiol; 2015; 10(10):1649-57. PubMed ID: 26439907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile colitis: pathogenesis and host defence.
    Abt MC; McKenney PT; Pamer EG
    Nat Rev Microbiol; 2016 Oct; 14(10):609-20. PubMed ID: 27573580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates.
    Lewis BB; Carter RA; Pamer EG
    Anaerobe; 2016 Oct; 41():32-36. PubMed ID: 27241781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.
    Khanna S; Pardi DS
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):409-16. PubMed ID: 20678014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. John G. Bartlett: Contributions to the discovery of Clostridium difficile antibiotic-associated diarrhea.
    Gorbach SL
    Clin Infect Dis; 2014 Sep; 59 Suppl 2():S66-70. PubMed ID: 25151480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice.
    Pultz NJ; Donskey CJ
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3529-32. PubMed ID: 16048976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: antibiotic-induced Clostridium difficile infection.
    Settle CD; Wilcox MH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):835-41. PubMed ID: 8971278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenicity of Clostridium difficile.
    Poxton IR; McCoubrey J; Blair G
    Clin Microbiol Infect; 2001 Aug; 7(8):421-7. PubMed ID: 11591205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for low risk of Clostridium difficile infection associated with tigecycline.
    Wilcox MH
    Clin Microbiol Infect; 2007 Oct; 13(10):949-52. PubMed ID: 17697004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial-associated risk factors for Clostridium difficile infection.
    Owens RC; Donskey CJ; Gaynes RP; Loo VG; Muto CA
    Clin Infect Dis; 2008 Jan; 46 Suppl 1():S19-31. PubMed ID: 18177218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile--a continually evolving and problematic pathogen.
    Dawson LF; Valiente E; Wren BW
    Infect Genet Evol; 2009 Dec; 9(6):1410-7. PubMed ID: 19539054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.
    Andréjak M; Schmit JL; Tondriaux A
    Drug Saf; 1991; 6(5):339-49. PubMed ID: 1930740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.
    Huang H; Weintraub A; Fang H; Nord CE
    Scand J Infect Dis; 2009; 41(2):158-9. PubMed ID: 18846478
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunization strategies for Clostridium difficile infections.
    Rebeaud F; Bachmann MF
    Expert Rev Vaccines; 2012 Apr; 11(4):469-79. PubMed ID: 22551032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clostridium difficile-associated diarrhea--an increasing problem. Reduce the administration of antibiotics and improve hygiene!].
    Svenungsson B
    Lakartidningen; 1996 Aug; 93(35):2931-4. PubMed ID: 8815352
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics and community Clostridium difficile infection.
    Jaques H
    Nurs Times; 2014 Jul 2-8; 110(27):19. PubMed ID: 25095570
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clostridium difficile infections. Not just a hospital problem].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Jun; 152(24):19. PubMed ID: 20672581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.